Sean David to Humans
This is a "connection" page, showing publications Sean David has written about Humans.
Connection Strength
0.987
-
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
Score: 0.031
-
Whole genome sequence analysis of blood lipid levels in >66,000 individuals. Nat Commun. 2022 Oct 11; 13(1):5995.
Score: 0.027
-
Implementing Primary Care Mediated Population Genetic Screening Within an Integrated Health System. J Am Board Fam Med. 2021 Jul-Aug; 34(4):861-865.
Score: 0.025
-
Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720981297.
Score: 0.022
-
Clinical and Personal Utility of Genetic Risk Testing. Am Fam Physician. 2018 05 01; 97(9):600-602.
Score: 0.020
-
Potential Reporting Bias in Neuroimaging Studies of Sex Differences. Sci Rep. 2018 04 17; 8(1):6082.
Score: 0.020
-
Whole genome sequence analyses of brain imaging measures in the Framingham Study. Neurology. 2018 01 16; 90(3):e188-e196.
Score: 0.020
-
Extended treatment for cigarette smoking cessation: a randomized control trial. Addiction. 2017 Aug; 112(8):1451-1459.
Score: 0.019
-
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016 06 29; 6(6):e010960.
Score: 0.018
-
Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. EBioMedicine. 2016 Feb; 4:153-61.
Score: 0.017
-
Gene by Environment Interaction Linking the Chromosome 15q25 Locus with Cigarette Consumption and Lung Cancer Susceptibility--Are African American Affected Differently?--Authors' Reply. EBioMedicine. 2016 Feb; 4:15.
Score: 0.017
-
Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable. Ann Fam Med. 2015 Jul-Aug; 13(4):373-80.
Score: 0.016
-
Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open. 2014 Mar 14; 4(3):e004393.
Score: 0.015
-
Commentary on Chen et?al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation? Addiction. 2014 Jan; 109(1):138-9.
Score: 0.015
-
Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Hum Brain Mapp. 2014 Jul; 35(7):3052-65.
Score: 0.015
-
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11.
Score: 0.015
-
Potential reporting bias in fMRI studies of the brain. PLoS One. 2013; 8(7):e70104.
Score: 0.014
-
Opioid antagonists for smoking cessation. Cochrane Database Syst Rev. 2013 Jun 06; (6):CD003086.
Score: 0.014
-
Improving America's health requires community-level solutions: Folsom revisited. Am Fam Physician. 2012 Aug 15; 86(4):1-2.
Score: 0.013
-
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry. 2012 May 22; 2:e119.
Score: 0.013
-
Communities of solution: the Folsom Report revisited. Ann Fam Med. 2012 May-Jun; 10(3):250-60.
Score: 0.013
-
A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response. Nat Genet. 2021 Oct; 53(10):1504-1516.
Score: 0.013
-
Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program. Genome Med. 2021 08 26; 13(1):136.
Score: 0.013
-
Genome sequencing unveils a regulatory landscape of platelet reactivity. Nat Commun. 2021 Jun 15; 12(1):3626.
Score: 0.012
-
Variant-specific inflation factors for assessing population stratification at the phenotypic variance level. Nat Commun. 2021 Jun 09; 12(1):3506.
Score: 0.012
-
Use of prechemotherapy positron emission tomography-CT imaging, acquired in the treatment position, to help plan involved nodal radiotherapy for a patient with diffuse large B-cell lymphoma. J Med Imaging Radiat Oncol. 2011 Apr; 55(2):236-41.
Score: 0.012
-
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res. 2011 Mar; 13(3):157-67.
Score: 0.012
-
Effect of Sickle Cell Trait and APOL1 Genotype on the Association of Soluble uPAR with Kidney Function Measures in Black Americans. Clin J Am Soc Nephrol. 2021 Feb 08; 16(2):287-289.
Score: 0.012
-
Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. Nicotine Tob Res. 2010 Mar; 12(3):251-62.
Score: 0.011
-
Genetic variation in the dopamine pathway and smoking cessation. Pharmacogenomics. 2008 Sep; 9(9):1307-21.
Score: 0.010
-
Deep-coverage whole genome sequences and blood lipids among 16,324 individuals. Nat Commun. 2018 08 23; 9(1):3391.
Score: 0.010
-
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85.
Score: 0.010
-
Smoking cessation in primary care. BMJ. 2008 May 31; 336(7655):1200-1.
Score: 0.010
-
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 12; 9(12):1251-7.
Score: 0.010
-
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res. 2007 Aug; 9(8):821-33.
Score: 0.009
-
Successful Latino community partnership program for smoking cessation. Am J Public Health. 2007 Aug; 97(8):1348-9; author reply 1349.
Score: 0.009
-
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J. 2008 Apr; 8(2):122-8.
Score: 0.009
-
The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res. 2007 Feb; 9(2):225-31.
Score: 0.009
-
Building a successful research enterprise in family medicine: the Brown experience. Med Health R I. 2006 Aug; 89(8):281-4.
Score: 0.009
-
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 2005 Sep 15; 58(6):488-94.
Score: 0.008
-
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci. 2005 Mar 09; 25(10):2586-90.
Score: 0.008
-
Does providing hereditary breast cancer risk assessment support to practicing physicians decrease the likelihood of them discussing such risk with their patients? Genet Med. 2004 Nov-Dec; 6(6):542.
Score: 0.008
-
Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. Med Health R I. 2004 Nov; 87(11):336-40.
Score: 0.008
-
Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With Breast Cancer. JAMA Netw Open. 2024 05 01; 7(5):e249449.
Score: 0.008
-
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
Score: 0.007
-
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trial. Addiction. 2024 04; 119(4):664-676.
Score: 0.007
-
Should we offer routine breast cancer screening with mammography? Am Fam Physician. 2003 Jul 15; 68(2):260-2.
Score: 0.007
-
Genetic susceptibility to breast cancer: teaching points. Fam Med. 2003 Jul-Aug; 35(7):466-8.
Score: 0.007
-
Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels". Nicotine Tob Res. 2003 Jun; 5(3):397-9.
Score: 0.007
-
Communities of solution: partnerships for population health. J Am Board Fam Med. 2013 May-Jun; 26(3):232-8.
Score: 0.007
-
Are family physicians willing to use pharmacogenetics for smoking cessation therapy? Fam Med. 2003 Feb; 35(2):83.
Score: 0.007
-
Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing. Nat Genet. 2023 Feb; 55(2):291-300.
Score: 0.007
-
Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature. 2022 12; 612(7941):720-724.
Score: 0.007
-
Cross-sectional online survey of clinicians' knowledge, attitudes and challenges to screening and counselling adolescents and young adults for substance use. BMJ Open. 2022 11 22; 12(11):e059019.
Score: 0.007
-
Should we prescribe antibiotics for acute conjunctivitis? Am Fam Physician. 2002 Nov 01; 66(9):1649-50.
Score: 0.007
-
A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies. Nat Methods. 2022 Dec; 19(12):1599-1611.
Score: 0.007
-
Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals. Nat Commun. 2022 Aug 22; 13(1):4923.
Score: 0.007
-
The mental health burden of racial and ethnic minorities during the COVID-19 pandemic. PLoS One. 2022; 17(8):e0271661.
Score: 0.007
-
Should we use multiple risk factor interventions for the primary prevention of coronary heart disease? Am Fam Physician. 2002 Jul 15; 66(2):245-6.
Score: 0.007
-
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022 04 23; 399(10335):1618-1624.
Score: 0.007
-
No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics. 2002 Apr; 12(3):265-8.
Score: 0.007
-
Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data. Nat Genet. 2022 Mar; 54(3):263-273.
Score: 0.007
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2021 11 30; 11:CD011823.
Score: 0.006
-
Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease. Circulation. 2022 Feb; 145(5):357-370.
Score: 0.006
-
Should we recommend nicotine replacement therapy? Am Fam Physician. 2001 Jun 01; 63(11):2245-7.
Score: 0.006
-
Target specific serologic analysis of COVID-19 convalescent plasma. PLoS One. 2021; 16(4):e0249938.
Score: 0.006
-
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium. Genome Med. 2021 Apr 21; 13(1):66.
Score: 0.006
-
Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices. Nat Commun. 2021 04 12; 12(1):2182.
Score: 0.006
-
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021 Feb; 590(7845):290-299.
Score: 0.006
-
Social marketing: application to medical education. Ann Intern Med. 2001 Jan 16; 134(2):125-7.
Score: 0.006
-
Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020 10; 586(7831):763-768.
Score: 0.006
-
Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale. Nat Genet. 2020 Sep; 52(9):969-983.
Score: 0.006
-
The association between cigarette smoking, cancer screening, and cancer stage: a prospective study of the women's health initiative observational cohort. BMJ Open. 2020 08 13; 10(8):e037945.
Score: 0.006
-
Perspectives on Precision Health Among Racial/Ethnic Minority Communities and the Physicians That Serve Them. Ethn Dis. 2020; 30(Suppl 1):137-148.
Score: 0.006
-
De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population. Proc Natl Acad Sci U S A. 2020 02 04; 117(5):2560-2569.
Score: 0.006
-
Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma. Chest. 2019 12; 156(6):1068-1079.
Score: 0.006
-
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence? Nicotine Tob Res. 2019 08 19; 21(9):1289-1293.
Score: 0.005
-
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019 02; 51(2):237-244.
Score: 0.005
-
Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. Mol Psychiatry. 2020 10; 25(10):2392-2409.
Score: 0.005
-
Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use. Biol Psychiatry. 2019 06 01; 85(11):946-955.
Score: 0.005
-
Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. Nat Commun. 2018 07 04; 9(1):2606.
Score: 0.005
-
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics. 2018 07 01; 19(10):861-871.
Score: 0.005
-
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. Nicotine Tob Res. 2018 03 06; 20(4):403-413.
Score: 0.005
-
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. Nicotine Tob Res. 2018 03 06; 20(4):414-424.
Score: 0.005
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017 09 08; 9:CD011823.
Score: 0.005
-
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 11; 14(11):1430-1468.
Score: 0.005
-
Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial. J Gen Intern Med. 2016 Feb; 31(2):172-181.
Score: 0.004
-
Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Mol Carcinog. 2016 10; 55(10):1424-37.
Score: 0.004
-
Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students. Prev Med. 2015 Mar; 72:56-63.
Score: 0.004
-
Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative. J Am Acad Dermatol. 2015 Jan; 72(1):190-1.e3.
Score: 0.004
-
Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers. Nicotine Tob Res. 2015 Jul; 17(7):855-61.
Score: 0.004
-
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. Clin Pharmacol Ther. 2014 Aug; 96(2):256-65.
Score: 0.004
-
No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Menopause. 2014 Apr; 21(4):415-20.
Score: 0.004
-
Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine Tob Res. 2014 Jul; 16(7):939-47.
Score: 0.004
-
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci. 2014 May; 18(5):235-41.
Score: 0.004
-
Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014 Mar 12; 311(10):1035-45.
Score: 0.004
-
Teaching tobacco dependence treatment and counseling skills during medical school: rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial. Contemp Clin Trials. 2014 Mar; 37(2):284-93.
Score: 0.004
-
Tobacco dependence treatment teaching by medical school clerkship preceptors: survey responses from more than 1,000 US medical students. Prev Med. 2013 Aug; 57(2):81-6.
Score: 0.004
-
Biomarkers for smoking cessation. Clin Pharmacol Ther. 2013 Jun; 93(6):526-38.
Score: 0.004
-
Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb; 15(2):518-26.
Score: 0.003
-
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. Pharmacogenet Genomics. 2012 Sep; 22(9):695-708.
Score: 0.003
-
Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
Score: 0.003
-
The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res. 2012 Apr 30; 202(1):20-9.
Score: 0.003
-
Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers. Ann Behav Med. 2012 Apr; 43(2):253-61.
Score: 0.003
-
Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers. J Hum Hypertens. 2013 Jan; 27(1):24-30.
Score: 0.003
-
Chronic psychosocial stressors and salivary biomarkers in emerging adults. Psychoneuroendocrinology. 2012 Aug; 37(8):1158-70.
Score: 0.003
-
Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. Eur J Endocrinol. 2011 Dec; 165(6):961-7.
Score: 0.003
-
Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet. 2011 Sep; 7(9):e1002280.
Score: 0.003
-
Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):7-13.
Score: 0.003
-
Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011 May; 106(5):985-94.
Score: 0.003
-
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J. 2012 Feb; 12(1):86-92.
Score: 0.003
-
Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res. 2010 Jul 30; 183(1):69-74.
Score: 0.003
-
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 2010 Mar; 11(3):357-67.
Score: 0.003
-
Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res. 2009 Jan; 11(1):64-76.
Score: 0.003
-
[Smoking cessation]. Praxis (Bern 1994). 2008 Nov 05; 97(22):1185-6.
Score: 0.003
-
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008 Jun; 65(6):683-93.
Score: 0.003
-
Smoking cessation. BMJ. 2008 Jan 26; 336(7637):217.
Score: 0.002
-
Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study. Nicotine Tob Res. 2008 Jan; 10(1):137-47.
Score: 0.002
-
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res. 2008 Jan; 10(1):231-40.
Score: 0.002
-
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1065-9.
Score: 0.002
-
Fellowship training in family medicine at Brown: adding depth to breadth. Med Health R I. 2006 Aug; 89(8):274-5.
Score: 0.002
-
Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res. 2004 Oct; 6(5):769-76.
Score: 0.002